Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Tarlatamab Exposure-Efficacy and Exposure-Safety Relationships to Inform Dose Selection in Patients with Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2025
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Journal: The New England journal of medicine
Published: June 02, 2025
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer.
Journal: Future oncology (London, England)
Published: November 12, 2024
Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancer.
Journal: The oncologist
Published: March 29, 2024
Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study.
Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 28, 2024
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: October 20, 2023
Showing 1-6 of 6
Last Updated: 09/26/2026